GlassScriptPhysician profile
Kirk Grogan
NPI 1790856524
$1,050.02
in general payments reported to CMS, 2019-2025
16 companies · $99.10 in 2025
The $99.10 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $40.49 · 2021: $56.90 · 2022: $86.88 · 2023: $196 · 2024: $185 · 2025: $99.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $253.00 | 2019 | |
| Novo Nordisk INC | $138.10 | 2022-2024 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $119.25 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Mimedx Group, INC. | $105.18 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $67.56 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $66.69 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.07 | 2023-2024 | Jardiance |
| Zimmer Biomet Holdings, INC. | $41.78 | 2019 | |
| Smith+Nephew, INC. | $33.67 | 2021 | |
| Averitas Pharma INC. | $30.02 | 2023 | Qutenza |
| Kyowa Kirin, INC. | $26.37 | 2023 | |
| Dexcom, INC. | $24.22 | 2024 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $23.12 | 2019 | |
| Cequr Corporation | $22.75 | 2023 | Cequr Simplicity |
| Amgen INC. | $18.66 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $16.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Grogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.